Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Oncogene
|
July 17, 1997
p53-mediated accumulation of hypophosphorylated pRb after the G1 restriction point fails to halt cell cycle progression
S P Linke, M P Harris, S E Neugebauer, et al.
Human Gene Therapy
|
November 1, 1995
Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography
B G Huyghe, X Liu, S Sutjipto, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1986
Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells
J S Patton, H M Shepard, H Wilking, et al.
Breast Cancer Research and Treatment
|
January 1, 1993
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
C C Benz, G K Scott, J C Sarup, et al.
Growth Regulation
|
June 1, 1991
Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth
J C Sarup, R M Johnson, K L King, et al.
Journal of Clinical Pathology
|
August 1, 1992
HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies
A H Arnaout, P M Dawson, S Soomro, et al.
Cancer Gene Therapy
|
March 1, 1996
Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein
M P Harris, S Sutjipto, K N Wills, et al.
Journal of Clinical Immunology
|
May 11, 1991
Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic
H M Shepard, G D Lewis, J C Sarup, et al.
The Journal of Biological Chemistry
|
August 5, 1991
p185HER2 signal transduction in breast cancer cells
G K Scott, J M Dodson, P A Montgomery, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 15, 1992
Humanization of an anti-p185HER2 antibody for human cancer therapy
P Carter, L Presta, C M Gorman, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Oncogene
|
July 17, 1997
p53-mediated accumulation of hypophosphorylated pRb after the G1 restriction point fails to halt cell cycle progression
S P Linke, M P Harris, S E Neugebauer, et al.
Human Gene Therapy
|
November 1, 1995
Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography
B G Huyghe, X Liu, S Sutjipto, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1986
Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells
J S Patton, H M Shepard, H Wilking, et al.
Breast Cancer Research and Treatment
|
January 1, 1993
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
C C Benz, G K Scott, J C Sarup, et al.
Growth Regulation
|
June 1, 1991
Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth
J C Sarup, R M Johnson, K L King, et al.
Journal of Clinical Pathology
|
August 1, 1992
HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies
A H Arnaout, P M Dawson, S Soomro, et al.
Cancer Gene Therapy
|
March 1, 1996
Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein
M P Harris, S Sutjipto, K N Wills, et al.
Journal of Clinical Immunology
|
May 11, 1991
Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic
H M Shepard, G D Lewis, J C Sarup, et al.
The Journal of Biological Chemistry
|
August 5, 1991
p185HER2 signal transduction in breast cancer cells
G K Scott, J M Dodson, P A Montgomery, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 15, 1992
Humanization of an anti-p185HER2 antibody for human cancer therapy
P Carter, L Presta, C M Gorman, et al.
Page
of 6